Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.

Item
http://www.wikidata.org/entity/Q33471998
The Treatment of IgA NephropathySteroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.Corticosteroid therapy in IgA nephropathy.Predicting the risk for dialysis or death in IgA nephropathy.Long-term results of a randomized controlled trial in childhood IgA nephropathy.Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.Use of low-dose sulodexide in IgA nephropathy patients on renin-angiotensin system blockadesDirect inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis.Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.Clinical characteristics of IgA nephropathy associated with low complement 4 levels.A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
P2860

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.

Item
http://www.wikidata.org/entity/Q33471998
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Efficacy and safety of glucoco ...... randomized controlled trials.
@ast
Efficacy and safety of glucoco ...... randomized controlled trials.
@en
type
label
Efficacy and safety of glucoco ...... randomized controlled trials.
@ast
Efficacy and safety of glucoco ...... randomized controlled trials.
@en
prefLabel
Efficacy and safety of glucoco ...... randomized controlled trials.
@ast
Efficacy and safety of glucoco ...... randomized controlled trials.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Efficacy and safety of glucoco ...... randomized controlled trials.
@en
P2093
P304
P31
P356
P433
P478
P577
P698